ArticleMedComm2025

Targeting LIF With Cyclovirobuxine D to Suppress Tumor Progression via LIF/p38MAPK/p62-Modulated Mitophagy in Hepatocellular Carcinoma.

Yingying Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.